Good Morning HIMR board. Been busy this week, and have

New Post Public Reply Private Reply Replies (1) Message Board
Kgem

Good Morning HIMR board. Been busy this week, and have not had a lot of time to post. Hollund released some very good news this week stating the Class C share issue is now resolved, and even initiating a share buy-back and retirement program. Fantastic News!

However, we also had an extreme amount of volume, and as usual the shouts of dilution always drown out all others. I don’t know exactly what is going on, and no one really does except for Hollund. But, it does not make sense to start a share buy-back program and then dilute. So why should this be the first conclusion people jump to? I suggest people jump to this conclusion because it is so easy, it does not require much thinking, and because dilution is so common in the pink sheets.

I read posts saying Hollund is not buying back shares right now because they do not have the money to do so. But does anyone really know? People cite the last financial statement where it said Hollund only had around eleven hundred dollars. Yet they acquired a concession, bought a larger percentage of the business partnership in Panama, and now announce a share buy-back. So does anyone with a brain cell working really think everything remained the same?

Hollund management, IR, and an owner close to the company told me wealthy individuals were waiting in the wings to jump in once Hollund started operations. It was suggested these individuals had deep pockets and could fund Hollund’s future and continued development. I was also told the company likely to build the TigerLynk desperately wants this technology, and would even pay the cost of building one on their own. Is any of this happening? We don’t know.

What we do know is that we are bouncing around our support level and holding pretty darn well. We are now in February, and this is the month Hollund is finally starting operations --- so pictures of same should soon be on the way. So forward progress is continuing, although slower than some might want it to be.

I was fortunate, I didn’t have the time to fret and worry about every single tick all throughout the day, and next week might be just as busy for me. The result. My account looks much like it did the week before, and my nerves were not really frazzled at all. Will the volume continue? I don’t know. Is the volume bad for us? It doesn’t appear so. Does the volume mean we are heading for a reverse split? Not likely if Hollund is buying back shares.

So I suggest that the only people suggesting the sky is now falling are the flippers and the worry warts who populate these boards. People, do yourself a favor. Relax, take a deep breath, and if need be just walk away. As long as your personal account remains largely the same, you lose absolutely nothing. Hollund is still the same company. Hollund’s business concept is still just as wonderful. And, if you dream of a buy-out or merger, we might be closer than ever before (not saying this is what I am hoping for right away, but I know some are).

Hollund Industrial Marine Inc. (HIMR) Stock Research Links

HIMR Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hair Syrup's Big U.S. Leap: Target Welcomes Viral Brand

Updated Category News Views 2

From Kitchen Experiment to U.S. Debut Here's a story that barely fits the tight mold of your typical business textbook. Hair Syrup, born from the brain of a university student tinkering at her kitchen table, is about to make waves across the pond. Lucie Macleod did what many dream of—she took a DIY hair oil project and spun it into a multimillion-dollar brand, now set...

Continue Reading
Cove Capital Secures $9.96M for Debt-Free Logistics DST

Updated Category News Views 1

Unpacking Cove Capital's Latest Victory Cove Capital Investments has pulled off another coup, raising a hefty $9,964,510 for its Cove Essential Net Lease Industrial 108 DST. It's a Regulation D, Rule 506(c) offering, now fully subscribed, spotlighting a debt-free investment ethos and a rock-solid logistics site in Anchorage, Alaska. Strategic Facility Anchoring Investment...

Continue Reading
Shareholder Rights in Focus: Examining Key Buyouts

Updated Category News Views 0

Shareholder Concerns Rise Amid Corporate Buyouts The stakes are high for the shareholders of Distribution Solutions Group, Eagle Financial Services, Safety Insurance Group, and Utz Brands as their companies face potential buyouts. Let's chew over what's on the table: the sweet deals insiders might score and the legal maneuvers in play. Halper Sadeh LLC, a heavy-hitting...

Continue Reading
RARE Foundation Rebrands, Focus Still Strong

Updated Category News Views 2

Unveiling the RARE Foundation's New Identity In the stock market, you ride waves of change, and let me tell you, it ain't just stocks and bonds that change names and faces. Case in point: The EveryLife Foundation for Rare Diseases has spiffed up as the RARE Foundation. New name, new logo, the whole enchilada. This isn't just a cosmetic touch-up, though. It's about...

Continue Reading
EFSI Shareholders on Alert Amid M&A Deal Scrutiny

Updated Category News Views 3

Eagle Financial Services Under the Microscope A buzz is picking up in the world of mergers and acquisitions, and this time, it's Eagle Financial Services, Inc. (NASDAQ: EFSI) caught in the crosshairs. What's the chatter all about? Well, it looks like Juan Monteverde and his crew over at Monteverde & Associates PC have set their sights on Eagle's proposed sale to John...

Continue Reading
Aflac's $200M Milestone in Cancer Charity Support

Updated Category News Views 0

Pioneering Efforts Across Decades Here’s an effort that bucks the usual corporate talk. Aflac, the supplemental insurance giant, isn’t just mumbling about its mission; it's doing the heavy lifting in the fight against childhood cancer and blood disorders. With over $200 million in contributions poured into the cause over more than 30 years, they're putting the capital...

Continue Reading
Monib Zirvi's Dermatology Excellence Honored in 2026

Updated Category News Views 3

Trailblazer in Dermatology Recognized Again Fancy yourself a star in dermatology? Well, take notes from Dr. Monib A. Zirvi. The guy just got his due recognition from Marquis Who's Who for his sizable contributions to dermatology and research. For someone who's been at this game for over two decades, Zirvi doesn't just glide by on old merits. He's the real deal, and his...

Continue Reading
Cap Juluca: Caribbean Luxury Redefined on Maundays Bay

Updated Category News Views 0

The Tranquil Call of Maundays Bay Find me dipping my toes in the sands of Maundays Bay come October 10, 2026, and you'll understand why this slice of Anguilla stakes its claim to being the best beach on the globe. Cap Juluca, that crown jewel of Caribbean luxury, swings open its doors once more, promising indulgence framed by turquoise waters and the soft whisper of white...

Continue Reading
Are FULC, WEAV, TECH Shareholders Getting a Raw Deal?

Updated Category News Views 2

Pocketing Insider Gains Amidst Shareholder Concerns Let me tell you, it smells like another day in the financial jungle where insiders might be feasting while the regular Joe shareholders are left nibbling on crumbs. Fulcrum Therapeutics, Weave Communications, and Bio-Techne are in the crosshairs for deals that may favor those on the inside track over you and me, the...

Continue Reading
Fresh Thyme Empowers Local Brands in Michigan Debut

Updated Category News Views 2

A Community-Driven Retail Innovation The grocery game just got a little more personal in Michigan, and we're not talking about run-of-the-mill retail pitches. Fresh Thyme Market, known for its commitment to local and natural products, is shaking things up with their Pitch Thyme Competition. This ain’t your usual product presentation. It’s a whole new ball game where...

Continue Reading

Top 5 Most Recently Viewed Articles

Sofwave Medical's Strategic Presence at Upcoming MedTech Summit

Updated Category News Views 262

Sofwave Medical's Strategic Participation in the Upcoming MedTech Summit Sofwave Medical Ltd, a leading innovator in non-invasive aesthetic medical devices, has announced its participation in an exciting virtual event. The Jefferies Private MedTech Summit serves as a platform for companies to showcase their latest innovations and connect with investors. This summit will...

Continue Reading
Defense Metals Welcomes New Leadership to Enhance Strategy

Updated Category News Views 135

New Leadership Signals Growth for Defense Metals Corp. Defense Metals Corp. is embarking on a new chapter with significant changes in leadership that aim to enhance its operational capabilities and strategic direction. The appointment of Mr. Mark Tory as President and Chief Executive Officer marks a pivotal moment for the Company. He takes over from Dr. Luisa Moreno, who...

Continue Reading
Dream Pairs Achieves Landmark Victory in Trademark Litigation

Updated Category News Views 131

Dream Pairs Achieves Landmark Victory in Trademark Litigation Dream Pairs, a prominent footwear brand under Miracle Miles Group Inc., successfully navigated a high-profile trademark dispute in the United Kingdom. This case involved allegations that Dream Pairs' distinctive logo, used on its football boots, infringed upon Iconix's "double diamond" trademarks. The decision...

Continue Reading
Significant Aluminum Auction: U.S. Customs Sells 22,000 Tons

Updated Category News Views 88

U.S. Customs to Auction Seized Aluminum In a significant move, U.S. Customs has announced an upcoming auction of 22,000 tons of seized aluminum. This auction is poised to attract attention from various industries that utilize aluminum for numerous applications, presenting a unique opportunity for both small and large enterprises. Understanding the Aluminum Market The...

Continue Reading
Monopar Therapeutics Announces New Equity Offering Plans

Updated Category News Views 93

Monopar Therapeutics Launches New Stock Offerings Monopar Therapeutics Inc. (NASDAQ: MNPR), a clinical-stage biopharmaceutical company, is making headlines with its substantial progress. The company has recently announced the pricing for a new stock offering, alongside a concurrent private placement of pre-funded warrants. Over the past year, Monopar's stock has seen an...

Continue Reading